|
TMEM20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.03880000052104E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58051999999964E-05 |
| Normal-vs-Stage2 |
8.697500E-02 |
| Normal-vs-Stage3 |
1.08809999899151E-08 |
| Normal-vs-Stage4 |
1.5887000048842E-08 |
| Stage1-vs-Stage2 |
2.802600E-01 |
| Stage1-vs-Stage3 |
3.646200E-02 |
| Stage1-vs-Stage4 |
5.215900E-03 |
| Stage2-vs-Stage3 |
1.281870E-02 |
| Stage2-vs-Stage4 |
3.104300E-03 |
| Stage3-vs-Stage4 |
3.098400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.99539964948781E-10 |
| Normal-vs-AfricanAmerican |
5.044600E-01 |
| Normal-vs-Asian |
2.297100E-03 |
| Caucasian-vs-AfricanAmerican |
2.177700E-02 |
| Caucasian-vs-Asian |
3.074800E-01 |
| AfricanAmerican-vs-Asian |
2.061200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.84870000045024E-07 |
| Normal-vs-Female |
2.21730000027343E-07 |
| Male-vs-Female |
4.092600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.9142000000103E-06 |
| Normal-vs-Age(41-60Yrs) |
2.79840000061427E-08 |
| Normal-vs-Age(61-80Yrs) |
1.055300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.958000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.709200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.397000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.894600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.306600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.865000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.029600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.28369603414581E-11 |
| Classical-VS-Follicular |
1.51739999454392E-08 |
| Classical-VS-Other |
6.970400E-01 |
| Classical-VS-Normal |
4.76219952361134E-10 |
| Tall-VS-Follicular |
1.62447832963153E-12 |
| Tall-VS-Other |
1.684750E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.557700E-02 |
| Follicular-VS-Normal |
2.768600E-01 |
| Other-VS-Normal |
1.403630E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.540110E-03 |
| Normal-vs-N1 |
2.24270000004356E-06 |
| N0-vs-N1 |
1.366440E-02 |
|
|
